Denali Therapeutics DNLI
NASDAQ DNLI
$20.00 -0.53 (-2.58%)
At close: Oct 2, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Non Operating Investment Income (2024)

Updated

Denali Therapeutics (DNLI) recorded Non Operating Investment Income of $14.54 million in FY2024.

Analysis

Denali Therapeutics (DNLI) Non Operating Investment Income (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Denali Therapeutics 3.20 Bn 3.20 Bn 3.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 14.54 Mn
API Access

Denali Therapeutics Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=DNLI&period=max&api_key=YOUR_API_KEY